Publications

Primary Results of the Phase Iii Javelin Head & Neck 100 Trial: Avelumab plus Chemoradiotherapy (Crt) Followed by Avelumab Maintenance Vs Crt in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (La Scchn)

AuthID
P-00S-WH2

Author(s)

Cohen, EE

Ferris, RL

Psyrri, A

Haddad, R

Tahara, M

Bourhis, J

Harrington, KJ

Chang, PMH

Lin, JC

Razaq, M

Teixeira, MM

Lovey, J

Chamois, J

Rueda Dominguez, AR

Hu, C

Dvorkin, M

De Beukelaer, S

Pavlov, D

Thurm, H

Lee, N

Document Type

Abstract

Year published

2020

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 31, Pages: S658-S658 (1)

Conference

Esmo Virtual Congress, Date: SEP 19-OCT 18, 2020, Location: ELECTR NETWORK, Sponsors: European Soc Med Oncol

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2020.08.1025

Wos: WOS:000573469101198

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Primary Results of the Phase Iii Javelin Head & Neck 100 Trial: Avelumab plus Chemoradiotherapy (Crt) Followed by Avelumab Maintenance Vs Crt in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (La Scchn)

Useful Links

Get Help

Federated Authentication (Click on the image)

Primary Results of the Phase Iii Javelin Head & Neck 100 Trial: Avelumab plus Chemoradiotherapy (Crt) Followed by Avelumab Maintenance Vs Crt in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (La Scchn)

Useful Links

Get Help